Addex Therapeutics (NASDAQ: ADXN) reported Q4 2023 earnings per share (EPS) of -$0.04, up 16.28% year over year. Total Addex Therapeutics earnings for the quarter were -$3.40 million. In the same quarter last year, Addex Therapeutics's earnings per share (EPS) was -$0.04.
As of Q2 2024, Addex Therapeutics's earnings has grown year over year. Addex Therapeutics's earnings in the past year totalled -$11.73 million.
What is ADXN's earnings date?
Addex Therapeutics's earnings date is Invalid Date. Add ADXN to your watchlist to be reminded of ADXN's next earnings announcement.
What was ADXN's revenue last quarter?
Addex Therapeutics (NASDAQ: ADXN) reported Q4 2023 revenue of $218.84 thousand up 66.02% year over year. In the same quarter last year, Addex Therapeutics's revenue was $643.95 thousand.
What was ADXN's revenue growth in the past year?
As of Q2 2024, Addex Therapeutics's revenue has grown 26.2% year over year. This is 125.26 percentage points lower than the US Biotechnology industry revenue growth rate of 151.46%. Addex Therapeutics's revenue in the past year totalled $1.83 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.